The HealthCare Institute of New Jersey (HINJ) is a trade association that since 1997 has served as the voice for our state’s leading research-based biopharmaceutical and medical technology companies.
HINJ strives to raise awareness and appreciation of the clinical and economic value of expanding patient access to medical innovations that improve outcomes and quality of life, and works to sustain the life sciences as New Jersey’s premier industry and a pillar of the state’s economy.
New Jersey proudly champions its life sciences industry and is globally recognized as the “Medicine Chest of the World” for its world-renowned cluster of life sciences companies.
For over 135 years, New Jersey has been a global leader in medical science. It offers a dynamic innovation ecosystem for researching and developing new medicines, therapies, diagnostics and technologies that improve the quality of patients’ lives. This includes over 3,200 life sciences companies and the largest concentration of scientists and engineers per square mile in the U.S.
We diligently monitor a number of policy debates — both in Washington, DC and Trenton.
HINJ President and CEO Chrissy Buteas was recently interviewed by Steve Adubato on his State of Affairs show to discuss New Jersey’s life sciences and our contributions to global human
An op-ed by Chrissy Buteas, HINJ President and Chief Executive Officer. New Prescription Drug Affordability Council must take a balanced approach that helps patients without harming potential cures The cost
by Chrissy Buteas, President and Chief Executive OfficerHealthCare Institute of New Jersey (HINJ) Trenton, October 31, 2024 ― I write in response to your editorial published on October 27. The
HealthCare Institute of New Jersey (HINJ)
222 W. State Street
Suite 302
Trenton, NJ 08608
Phone: 732-729-9619
©2023. HealthCare Institute of New Jersey (HINJ). All rights reserved.
